{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:19:47Z","timestamp":1772119187396,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Research Funds from Guangzhou Panyu Central Hospital","award":["PY-2023-007, PY-2023-010"],"award-info":[{"award-number":["PY-2023-007, PY-2023-010"]}]},{"name":"Pharmacy Research Foundation of Guangdong Provincial Hospital","award":["2024A31"],"award-info":[{"award-number":["2024A31"]}]},{"name":"Guangdong Basic and Applied Basic Research Fund Enterprise Joint Fund","award":["2023A1515220024"],"award-info":[{"award-number":["2023A1515220024"]}]},{"DOI":"10.13039\/501100003785","name":"Medical Research Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2024070"],"award-info":[{"award-number":["2024070"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00210-025-04365-8","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T03:42:39Z","timestamp":1750304559000},"page":"17735-17743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bioequivalence evaluation of dexamethasone palmitate injections by intravenous injection in healthy Chinese volunteers: a 2-period crossover trial"],"prefix":"10.1007","volume":"398","author":[{"given":"Bingna","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xihua","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoxing","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfen","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"issue":"11","key":"4365_CR1","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.clml.2020.06.022","volume":"20","author":"Q Bashir","year":"2020","unstructured":"Bashir Q, Acosta M (2020) Comparative safety, bioavailability, and pharmacokinetics of oral dexamethasone, 4-mg and 20-mg tablets, in healthy volunteers under fasting and fed conditions: a randomized open-label, 3-way crossover study. Clin Lymphoma Myeloma Leuk 20(11):768\u2013773. https:\/\/doi.org\/10.1016\/j.clml.2020.06.022","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4365_CR2","doi-asserted-by":"publisher","first-page":"15954","DOI":"10.1038\/srep15954","volume":"5","author":"N Bordag","year":"2015","unstructured":"Bordag N, Klie S, J\u00fcrchott K, Vierheller J, Schiewe H, Albrecht V, Tonn JC, Schwartz C, Schichor C, Selbig J (2015) Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects. Sci Rep 5:15954. https:\/\/doi.org\/10.1038\/srep15954","journal-title":"Sci Rep"},{"issue":"12","key":"4365_CR3","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1177\/106002809402801215","volume":"28","author":"TY Chan","year":"1994","unstructured":"Chan TY, Tsoi WW (1994) Cushing\u2019s syndrome caused by analgesic\/dexamethasone preparation. Ann Pharmacother 28(12):1411. https:\/\/doi.org\/10.1177\/106002809402801215","journal-title":"Ann Pharmacother"},{"issue":"29","key":"4365_CR4","doi-asserted-by":"publisher","first-page":"7254","DOI":"10.1002\/anie.201202713","volume":"51","author":"BJ Crielaard","year":"2012","unstructured":"Crielaard BJ, Rijcken CJ, Quan L, van der Wal S, Altintas I, van der Pot M, Kruijtzer JA, Liskamp RM, Schiffelers RM, van Nostrum CF, Hennink WE, Wang D, Lammers T, Storm G (2012) Glucocorticoid-loaded core-cross-linked polymeric micelles with tailorable release kinetics for targeted therapy of rheumatoid arthritis. Angew Chem Int Ed Engl 51(29):7254\u20137258. https:\/\/doi.org\/10.1002\/anie.201202713","journal-title":"Angew Chem Int Ed Engl"},{"issue":"2","key":"4365_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1089\/jop.2012.0044","volume":"29","author":"P Daull","year":"2013","unstructured":"Daull P, Paterson CA, Kuppermann BD, Garrigue JS (2013) A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema. J Ocul Pharmacol Ther 29(2):258\u2013269. https:\/\/doi.org\/10.1089\/jop.2012.0044","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"4365_CR6","doi-asserted-by":"publisher","first-page":"1353395","DOI":"10.1080\/20018525.2017.1353395","volume":"4","author":"Z Diamant","year":"2017","unstructured":"Diamant Z, Samuelsson Palmgren G, Westrin B, Bjermer L (2017) Phase I study evaluating the safety, tolerability and pharmacokinetics of a novel oral dissolvable film containing dexamethasone versus Fortecortin dexamethasone tablets. Eur Clin Respir J 4(1):1353395. https:\/\/doi.org\/10.1080\/20018525.2017.1353395","journal-title":"Eur Clin Respir J"},{"issue":"5","key":"4365_CR7","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/10903127.2018.1440039","volume":"22","author":"L Dylla","year":"2018","unstructured":"Dylla L, Acquisto NM, Manzo F, Cushman JT (2018) Dexamethasone-related perineal burning in the prehospital setting: a case series. Prehosp Emerg Care 22(5):655\u2013658. https:\/\/doi.org\/10.1080\/10903127.2018.1440039","journal-title":"Prehosp Emerg Care"},{"issue":"7 Suppl","key":"4365_CR8","first-page":"S128","volume":"20","author":"A Gibofsky","year":"2014","unstructured":"Gibofsky A (2014) Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis. Am J Manag Care 20(7 Suppl):S128\u2013135","journal-title":"Am J Manag Care"},{"key":"4365_CR9","doi-asserted-by":"publisher","unstructured":"Guo J, Huang F, Zhang J, Wu H, Song H, Xu H, Zhang R (2012) A multicenter, randomized, double-blind, controlled study on the injection of two kinds of dexamethasone palmitate in the treatment of rheumatoid arthritis. Chin J Rheumatol (06):393\u2013397. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-7480.2012.06.008","DOI":"10.3760\/cma.j.issn.1007-7480.2012.06.008"},{"issue":"7","key":"4365_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11095-019-2609-4","volume":"36","author":"L Hu","year":"2019","unstructured":"Hu L, Luo X, Zhou S, Zhu J, Xiao M, Li C, Zheng H, Qiu Q, Lai C, Liu X, Deng Y, Song Y (2019) Neutrophil-mediated delivery of dexamethasone palmitate-loaded liposomes decorated with a sialic acid conjugate for rheumatoid arthritis treatment. Pharm Res 36(7):97. https:\/\/doi.org\/10.1007\/s11095-019-2609-4","journal-title":"Pharm Res"},{"issue":"7","key":"4365_CR11","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/ard.2008.092163","volume":"68","author":"D Huscher","year":"2009","unstructured":"Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R, Zink A, Buttgereit F (2009) Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 68(7):1119\u20131124. https:\/\/doi.org\/10.1136\/ard.2008.092163","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4365_CR12","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.xphs.2020.10.023","volume":"110","author":"D Jadhav","year":"2021","unstructured":"Jadhav D, Vavia P (2021) Dexamethasone sodium phosphate loaded modified cyclodextrin based nanoparticles: an efficient treatment for rheumatoid arthritis. J Pharm Sci 110(3):1206\u20131218. https:\/\/doi.org\/10.1016\/j.xphs.2020.10.023","journal-title":"J Pharm Sci"},{"issue":"12","key":"4365_CR13","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/cpdd.985","volume":"10","author":"Z Li","year":"2021","unstructured":"Li Z, Liu J, Ju G, Yan K, Mao Y, Liu Q, Yang X, Zhang R, Qiu W (2021) Pharmacokinetics and bioequivalence evaluation of 2 formulations of tenofovir alafenamide. Clin Pharmacol Drug Dev 10(12):1519\u20131527. https:\/\/doi.org\/10.1002\/cpdd.985","journal-title":"Clin Pharmacol Drug Dev"},{"key":"4365_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jconrel.2019.01.015","volume":"296","author":"M Lorscheider","year":"2019","unstructured":"Lorscheider M, Tsapis N, Ur-Rehman M, Gaudin F, Stolfa I, Abreu S, Mura S, Chaminade P, Espeli M, Fattal E (2019) Dexamethasone palmitate nanoparticles: an efficient treatment for rheumatoid arthritis. J Control Release 296:179\u2013189. https:\/\/doi.org\/10.1016\/j.jconrel.2019.01.015","journal-title":"J Control Release"},{"issue":"5","key":"4365_CR15","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1021\/acsbiomaterials.2c00026","volume":"8","author":"VS Madamsetty","year":"2022","unstructured":"Madamsetty VS, Mohammadinejad R, Uzieliene I, Nabavi N, Dehshahri A, Garcia-Couce J, Seyfoddin A (2022) Dexamethasone: insights into pharmacological aspects, therapeutic mechanisms, and delivery systems. Acs Biomater Sci Eng 8(5):1763\u20131790. https:\/\/doi.org\/10.1021\/acsbiomaterials.2c00026","journal-title":"Acs Biomater Sci Eng"},{"issue":"9","key":"4365_CR16","first-page":"1631","volume":"72","author":"M Miura","year":"2014","unstructured":"Miura M (2014) Steroid pulse therapy. Nihon rinsho. Japanese journal of clinical medicine 72(9):1631\u20131635 (Retrieved from\u202f:\/\/MEDLINE:25518414)","journal-title":"Nihon rinsho. Japanese journal of clinical medicine"},{"issue":"4","key":"4365_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.medcli.2016.03.005","volume":"147","author":"J Narv\u00e1ez","year":"2016","unstructured":"Narv\u00e1ez J (2016) Treatment of rheumatoid arthritis. Med Clin (Barc) 147(4):176\u2013180. https:\/\/doi.org\/10.1016\/j.medcli.2016.03.005","journal-title":"Med Clin (Barc)"},{"issue":"1","key":"4365_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11010-022-04492-3","volume":"478","author":"P Prasad","year":"2023","unstructured":"Prasad P, Verma S, Surbhi GNK, Chaturvedi V, Mittal SA (2023) Rheumatoid arthritis: advances in treatment strategies. Mol Cell Biochem 478(1):69\u201388. https:\/\/doi.org\/10.1007\/s11010-022-04492-3","journal-title":"Mol Cell Biochem"},{"issue":"11","key":"4365_CR19","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.clinthera.2011.10.006","volume":"33","author":"C Queckenberg","year":"2011","unstructured":"Queckenberg C, Wachall B, Erlinghagen V, Di Gion P, Tomalik-Scharte D, Tawab M, Gerbeth K, Fuhr U (2011) Pharmacokinetics, pharmacodynamics, and comparative bioavailability of single, oral 2-mg doses of dexamethasone liquid and tablet formulations: a randomized, controlled, crossover study in healthy adult volunteers. Clin Ther 33(11):1831\u20131841. https:\/\/doi.org\/10.1016\/j.clinthera.2011.10.006","journal-title":"Clin Ther"},{"issue":"4","key":"4365_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.14712\/23362936.2021.23","volume":"122","author":"BK Saha","year":"2021","unstructured":"Saha BK, Milman NT (2021) Short review of liposteroid: a novel targeted glucocorticoid preparation for treatment of autoimmune and inflammatory diseases. Prague Med Rep 122(4):257\u2013268. https:\/\/doi.org\/10.14712\/23362936.2021.23","journal-title":"Prague Med Rep"},{"issue":"10055","key":"4365_CR21","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/s0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023\u20132038. https:\/\/doi.org\/10.1016\/s0140-6736(16)30173-8","journal-title":"Lancet"},{"issue":"5 Suppl 68","key":"4365_CR22","first-page":"S13","volume":"29","author":"C Strehl","year":"2011","unstructured":"Strehl C, Spies CM, Buttgereit F (2011) Pharmacodynamics of glucocorticoids. Clin Exp Rheumatol 29(5 Suppl 68):S13\u201318","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"4365_CR23","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/cpdd.1211","volume":"12","author":"J Su","year":"2023","unstructured":"Su J, Zhang C, Su Y, Huang C, Zhao J, Yang H, Xu Z, Li J, Yang X (2023) Pharmacokinetics, bioequivalence, and safety evaluation of two formulations of 0.2-g ibuprofen granules. Clin Pharmacol Drug Dev 12(6):588\u2013593. https:\/\/doi.org\/10.1002\/cpdd.1211","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"5 Suppl 35","key":"4365_CR24","first-page":"S77","volume":"22","author":"HB Townsend","year":"2004","unstructured":"Townsend HB, Saag KG (2004) Glucocorticoid use in rheumatoid arthritis: benefits, mechanisms, and risks. Clin Exp Rheumatol 22(5 Suppl 35):S77\u201382","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"4365_CR25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2177\/jsci.39.190","volume":"39","author":"H Wakiguchi","year":"2016","unstructured":"Wakiguchi H, Ohga S (2016) Clinical utility of the liposteroid therapy: potential effects on the macrophage activation. Nihon Rinsho Meneki Gakkai Kaishi 39(3):190\u2013196. https:\/\/doi.org\/10.2177\/jsci.39.190","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"issue":"8","key":"4365_CR26","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1208\/s12249-019-1449-1","volume":"20","author":"X Wang","year":"2019","unstructured":"Wang X, Feng Y, Fu J, Wu C, He B, Zhang H, Wang X, Dai W, Sun Y, Zhang Q (2019) A lipid micellar system loaded with dexamethasone palmitate alleviates rheumatoid arthritis. AAPS PharmSciTech 20(8):316. https:\/\/doi.org\/10.1208\/s12249-019-1449-1","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"4365_CR27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/cod.13334","volume":"81","author":"TJ Watts","year":"2019","unstructured":"Watts TJ, Thursfield D, Haque R (2019) Cutaneous adverse drug reaction induced by oral dexamethasone with possible cross-reactivity to Group 1 corticosteroids confirmed by patch testing and intradermal testing. Contact Dermatitis 81(5):384\u2013386. https:\/\/doi.org\/10.1111\/cod.13334","journal-title":"Contact Dermatitis"},{"key":"4365_CR28","doi-asserted-by":"publisher","unstructured":"World Medical Association (2013) World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20):2191\u20132194. https:\/\/doi.org\/10.1001\/jama.2013.281053","DOI":"10.1001\/jama.2013.281053"},{"issue":"5","key":"4365_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/s0887-8994(98)00003-4","volume":"18","author":"H Yamamoto","year":"1998","unstructured":"Yamamoto H, Asoh M, Murakami H, Kamiyama N, Ohta C (1998) Liposteroid (dexamethasone palmitate) therapy for West syndrome: a comparative study with ACTH therapy. Pediatr Neurol 18(5):415\u2013419. https:\/\/doi.org\/10.1016\/s0887-8994(98)00003-4","journal-title":"Pediatr Neurol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04365-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04365-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04365-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T04:30:52Z","timestamp":1764822652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04365-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4365"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04365-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4505796\/v1","asserted-by":"object"}]},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was registered in the Chinese Clinical Trial Registry (\n                      \n                      ; registration number ChiCTR2500098690; registered date: March 12, 2025)\u00a0and the China Drug Trials registry (\n                      \n                      ; registration number: CTR20211598; registration date: July 13, 2021). This clinical trial was approved by the Ethics Committee of Panyu Central Hospital and was conducted independently at the Phase I Clinical Trial Research Center of Panyu Central Hospital on September 20, 2021. The Clinical Research Ethics Committee approval number is PYZXYYEC [2021\u2013021]-01. This study complied with the requirements of the Declaration of Helsinki (World Medical Association\n                      \n                      ), Guidelines of Good Clinical Practice, and other related guiding principles.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the trial.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"No identifying details in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}